share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ANDO GORAN

SEC ·  Aug 22 04:06
Summary by Futu AI
Goran Ando, associated with EyePoint Pharmaceuticals, Inc. (EYPT), executed a purchase of 5,000 shares of common stock on August 21, 2024. The transaction was carried out on the open market at a price of $7.95 per share. Following this acquisition, Ando's direct holdings in the company increased to 13,150 shares. The transaction is currently reported as in progress.
Goran Ando, associated with EyePoint Pharmaceuticals, Inc. (EYPT), executed a purchase of 5,000 shares of common stock on August 21, 2024. The transaction was carried out on the open market at a price of $7.95 per share. Following this acquisition, Ando's direct holdings in the company increased to 13,150 shares. The transaction is currently reported as in progress.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated